Home › Chronic Myeloid Leukemia › Minnesota › Minneapolis
Chronic Myeloid Leukemia clinical trials in Minneapolis, MN
3 studies for Chronic Myeloid Leukemia are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi away
Allo HSCT Using RIC and PTCy for Hematological Diseases
RecruitingPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
RecruitingPhase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
About Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.
More about Chronic Myeloid Leukemia on MedlinePlus
Chronic Myeloid Leukemia trials in other cities
- Houston, TX18 studies
- New York City, NY11 studies
- Seattle, WA11 studies
- Birmingham, AL6 studies
- Detroit, MI6 studies
- Portland, OR6 studies
- Baldwin Park, CA6 studies
- Philadelphia, PA6 studies
- Chicago, IL6 studies
- Columbus, OH5 studies
- Nashville, TN5 studies
- Durham, NC5 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.